NCCM
SGMO

Nine Chapters Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Nine Chapters Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,200
Closed -$557K – 1154
2015
Q2 		$557K Sell
50,200
-14,700
-23% -$190K 0.05% 535
2015
Q1 		$1.02M Buy
64,900
+50,700
+357% +$784K 0.09% 369
2014
Q4 		$216K Sell
14,200
-83,000
-85% -$1.01M 0.02% 774
2014
Q3 		$1.05M Buy
97,200
+76,000
+358% +$993K 0.09% 293
2014
Q2 		$324K Buy
+21,200
New +$305K 0.03% 696

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Nine Chapters Capital Management's SGMO Position: Q3 2015 in Review

Nine Chapters Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2015, closing a stake of 50,200 shares — an estimated $557K sold.

Nine Chapters Capital Management first reported a position in SGMO in Q2 2014 and held it in 5 quarters. The position peaked at $1.05M in Q3 2014. 141 funds tracked by Wall St. Rank hold SGMO as of Q3 2015.

  • Nine Chapters Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 50,200 SANGAMO THERAPEUTICS INC shares in Q3 2015, an estimated $557K.
  • Nine Chapters Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 5 quarters.
  • Nine Chapters Capital Management's SANGAMO THERAPEUTICS INC position peaked at $1.05M in Q3 2014.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2015.

Based on Nine Chapters Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.